- Titre
- Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 Gaucher disease
- Créateurs - sans rôle
- Christine Serratrice - Department of internal medicine, Hôpital Saint Joseph, Marseille, France. Electronic address: cserratrice@hotmail.frMonia Bengherbia - Referal Center for Lysosomal Diseases, CHU Paris Nord Val de Seine, FranceMarine Alessandrini - EA 3279 Research Unit, Marseille, FranceBernard Grosbois - Université Rennes 1Fabrice Camou - Medical Intensive Care Unit, CHU Saint André, Bordeaux, FranceYves Marie Pers - Clinical immunology and osteoarticular diseases Therapeutic Unit, CHRU Lapeyronie, Montpellier, FranceMichael Bismuth - Department of gastroenterology, CHU Saint Eloi, Montpellier, FranceIsabelle Marie - Department of internal Medicine, CHU Rouen, Rouen, FranceNadia Belmatoug - Referal Center for Lysosomal Diseases, CHU Paris Nord Val de Seine, FranceMarc Berger - Department of hematology, CHU Estaing, Clermont Ferrand, FranceComité d'Evaluation et de Traitement de la maladie de Gaucher
- Détails de publication
- Blood cells, molecules, & diseases, Vol.53(1-2), pp.94-96
- Identifiants
- 99155831109311
- Unité académique
- Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 Gaucher disease
Blood cells, molecules, & diseases, Vol.53(1-2), pp.94-96
01/06/2014
PMID: 24411065
Indicateurs
1 Consultations de la notice